Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00466440
Status:
COMPLETED
Last Update Posted:
2020-11-06
First Post:
2007-04-25
Brief Title:
A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-25
First Submit QC Date:
April 25 2007
Study First Post Date:
2007-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-11-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-08-06
Disp First Submit QC Date:
August 6 2010
Disp First Post Date:
2010-08-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-10-09
Last Update Post Date:
2020-11-06
Last Update Post Date Type:
ACTUAL